Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896449067> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2896449067 endingPage "1650" @default.
- W2896449067 startingPage "1645" @default.
- W2896449067 abstract "Pemetrexed is a multitargeted antifolate indicated for locally advanced or metastatic non-squamous non-small-cell lung cancer and malignant pleural mesothelioma. Cutaneous reactions are associated with pemetrexed use. Pemetrexed prescribing information recommends oral dexamethasone 4 mg twice daily for three days starting the day before pemetrexed infusion to prevent cutaneous reactions. Patients receive intravenous dexamethasone before pemetrexed infusion at the University of New Mexico Comprehensive Cancer Center, but the oral dexamethasone recommendation is not always followed. The objective of this study was to determine if there is a difference between patients who received three days of oral dexamethasone starting the day before pemetrexed infusion and patients who did not by determining incidence of cutaneous reactions, delay in therapy, and therapy change due to adverse reactions. Eighty-five patients received at least one dose of pemetrexed between August 1, 2012 and August 31, 2017. Twenty-nine patients did not receive three days of oral dexamethasone 4 mg twice daily and 56 patients did (34.1% vs. 65.9%). There was no statistically significant difference in the incidence of cutaneous reactions between the intervention group and the control group (13.8% vs. 25.0%; p = 0.384), delay in pemetrexed therapy between groups (44.8% vs. 32.1%; p = 0.2), or therapy change due to adverse events (34.5% vs. 23.2%; p = 0.654). Results suggest three days of oral dexamethasone 4 mg twice daily did not significantly affect incidence rates of cutaneous reactions, delay in therapy, or therapy change in patients who received intravenous dexamethasone before pemetrexed infusion at University of New Mexico Comprehensive Cancer Center." @default.
- W2896449067 created "2018-10-26" @default.
- W2896449067 creator A5042879606 @default.
- W2896449067 creator A5062491355 @default.
- W2896449067 date "2018-10-14" @default.
- W2896449067 modified "2023-10-17" @default.
- W2896449067 title "Incidence of cutaneous reactions with pemetrexed: Comparison of patients who received three days of oral dexamethasone twice daily to patients who did not" @default.
- W2896449067 cites W1998421342 @default.
- W2896449067 cites W2113515867 @default.
- W2896449067 cites W2134667653 @default.
- W2896449067 cites W2142703207 @default.
- W2896449067 cites W2309777334 @default.
- W2896449067 cites W2139593370 @default.
- W2896449067 doi "https://doi.org/10.1177/1078155218804869" @default.
- W2896449067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30319062" @default.
- W2896449067 hasPublicationYear "2018" @default.
- W2896449067 type Work @default.
- W2896449067 sameAs 2896449067 @default.
- W2896449067 citedByCount "5" @default.
- W2896449067 countsByYear W28964490672019 @default.
- W2896449067 countsByYear W28964490672020 @default.
- W2896449067 countsByYear W28964490672021 @default.
- W2896449067 countsByYear W28964490672022 @default.
- W2896449067 countsByYear W28964490672023 @default.
- W2896449067 crossrefType "journal-article" @default.
- W2896449067 hasAuthorship W2896449067A5042879606 @default.
- W2896449067 hasAuthorship W2896449067A5062491355 @default.
- W2896449067 hasConcept C120665830 @default.
- W2896449067 hasConcept C121332964 @default.
- W2896449067 hasConcept C126322002 @default.
- W2896449067 hasConcept C141071460 @default.
- W2896449067 hasConcept C197934379 @default.
- W2896449067 hasConcept C2776694085 @default.
- W2896449067 hasConcept C2776804153 @default.
- W2896449067 hasConcept C2777240266 @default.
- W2896449067 hasConcept C2778239845 @default.
- W2896449067 hasConcept C2780401358 @default.
- W2896449067 hasConcept C61511704 @default.
- W2896449067 hasConcept C71924100 @default.
- W2896449067 hasConceptScore W2896449067C120665830 @default.
- W2896449067 hasConceptScore W2896449067C121332964 @default.
- W2896449067 hasConceptScore W2896449067C126322002 @default.
- W2896449067 hasConceptScore W2896449067C141071460 @default.
- W2896449067 hasConceptScore W2896449067C197934379 @default.
- W2896449067 hasConceptScore W2896449067C2776694085 @default.
- W2896449067 hasConceptScore W2896449067C2776804153 @default.
- W2896449067 hasConceptScore W2896449067C2777240266 @default.
- W2896449067 hasConceptScore W2896449067C2778239845 @default.
- W2896449067 hasConceptScore W2896449067C2780401358 @default.
- W2896449067 hasConceptScore W2896449067C61511704 @default.
- W2896449067 hasConceptScore W2896449067C71924100 @default.
- W2896449067 hasIssue "7" @default.
- W2896449067 hasLocation W28964490671 @default.
- W2896449067 hasOpenAccess W2896449067 @default.
- W2896449067 hasPrimaryLocation W28964490671 @default.
- W2896449067 hasRelatedWork W1966919723 @default.
- W2896449067 hasRelatedWork W2025427264 @default.
- W2896449067 hasRelatedWork W2030898400 @default.
- W2896449067 hasRelatedWork W2047967234 @default.
- W2896449067 hasRelatedWork W2079371985 @default.
- W2896449067 hasRelatedWork W2094973406 @default.
- W2896449067 hasRelatedWork W2368111095 @default.
- W2896449067 hasRelatedWork W2381290377 @default.
- W2896449067 hasRelatedWork W2395544729 @default.
- W2896449067 hasRelatedWork W2558365185 @default.
- W2896449067 hasVolume "25" @default.
- W2896449067 isParatext "false" @default.
- W2896449067 isRetracted "false" @default.
- W2896449067 magId "2896449067" @default.
- W2896449067 workType "article" @default.